RobertA.LafyatisMD
Rheumatology • Pittsburgh, PAProfessor, Medicine, Boston University School of Medicine
Dr. Lafyatis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 Fifth Avenue
Pittsburgh, PA 15213Phone+1 412-647-0943Fax+1 412-647-4050- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Rheumatology, 1986 - 1989
Wake Forest University School of MedicineResidency, Internal Medicine, 1984 - 1986- Wake Forest University School of MedicineInternship, Internal Medicine, 1983 - 1984
University of Cincinnati College of MedicineClass of 1983
Certifications & Licensure
PA State Medical License 2015 - 2024
MA State Medical License 1994 - 2017
NC State Medical License 1985 - 1999
MD State Medical License 1986 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Mycophenolate Mofetil in Systemic Sclerosis Start of enrollment: 2006 Mar 01
- Fresolimumab In Systemic Sclerosis Start of enrollment: 2011 Jan 01
- IL1-TRAP, Rilonacept, in Systemic Sclerosis Start of enrollment: 2011 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- SLIDE: Significant Latent Factor Interaction Discovery and Exploration across biological domains.Javad Rahimikollu, Hanxi Xiao, AnnaElaine Rosengart, Aaron B I Rosen, Tracy Tabib, Paul M Zdinak, Kun He, Xin Bing, Florentina Bunea, Marten Wegkamp, Amanda C Poholek,...> ;Nature Methods. 2024 Feb 19
- Long non-coding RNA H19X as a regulator of mononuclear cell adhesion to the endothelium in systemic sclerosis.Tirelli, F., Pachera, E., Gmür, S., Huang, M., Zulian, F., Camarillo Retamosa, E., Kania, G., Distler, O., Lafyatis, R.> ;Rheumatology. 2024 Feb 1
- Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.Feiyang Ma, Pei-Suen Tsou, Mehrnaz Gharaee-Kermani, Olesya Plazyo, Xianying Xing, Joseph Kirma, Rachael Wasikowski, Grace A Hile, Paul W Harms, Yanyun Jiang, Enze Xing...> ;Nature Communications. 2024 Jan 3
- Join now to see all
Journal Articles
- Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients with Diffuse Cutaneous Systemic SclerosisRobert Lafyatis, Yuqing Zhang, Arthritis & Rheumatology
Press Mentions
Forbius Announces the First Patient Dosed in a Phase 1b Diffuse Cutaneous Systemic Sclerosis Trial of AVID200, a Novel TGF-Beta 1 & 3 InhibitorMarch 4th, 2019
Rapid Skin Improvement Seen After Treating Systemic Sclerosis Patients with FresolimumabJune 22nd, 2015
Grant Support
- International Workshop On Scleroderma ResearchNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2012
- Rheumatic Diseases Research Core CentersNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Project 1 Biomarkers Of Disease Activity And Progression In Systemic SclerosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Niams: CortNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Innate Immunity In Dermal Fibrosis And Systemic SclerosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Tenth International Workshop On Scleroderma Research - August 2-6,2008, CambridgeNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2009
- Microarray Biomarkers Of Disease Activity And Progression In Systemic SclerosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
- Altered Elastogenesis By TSK Fibrillin-1 And In SSCNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2009
- Rituximab Treatment Of SclerodermaNational Center For Research Resources2007
- International Workshop For Scleroderma ResearchNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006
- Immune Mediated Alterations In Connective TissueNational Center For Research Resources2006
- Rituximab Treatment Of Scleroderma - An OPEN Label, Phase I StudyNational Center For Research Resources2005–2006
- SWAP And SR Protein Regulation Of Alternaive SplicingNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997
- Autoimmunity To And MRNA Splicing Regulation By SWAPNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1996
Professional Memberships
- Fellow
Hospital Affiliations
UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
UPMC Children's Hospital of PittsburghPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
